Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
448.00    13.50 (3.11%)
Bid:
447.00
Ask:
450.00
Spread: 3.00 (0.671%)
Market Cap: £220.33m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

10 Jul 2015 07:00

RNS Number : 6817S
Zotefoams PLC
10 July 2015
 



Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

 

10 July 2015 - Zotefoams, a world leader in cellular material technology, today provides a trading update for the six months ended 30 June 2015.

 

For the first six months of 2015 Zotefoams will deliver sales1 growth of approximately 8%, which is approximately 10% on a constant currency basis. Zotefoams expects revenue from MuCell Extrusion LLC, the Company's technology licensing business, to grow by around 40% and High-Performance Products ("HPP") sales growth to exceed 20%, building on the very strong HPP performance in 2014. The Company's Polyolefin foams sales volumes have increased by 6% and this is expected to deliver an increase in revenue of approximately 5%, equivalent to around 8% in constant currency. All three business units have strong forward order books.

 

The price of LDPE (Low Density Polyethylene), the Company's major raw material, was at a similar average euro price to the first half of 2014, although prices have risen sharply in recent months. The weaker euro has benefitted raw material purchases, which are significantly euro based, and US dollar sales have benefitted from the stronger dollar. However this has been more than offset by the impact of the euro on both Zotefoams' European sales and, in particular, the unhedged translational impact on the Company's balance sheet.

 

In Walton, Kentucky, USA, the major investment to increase global manufacturing capacity in support of future growth is proceeding to schedule.

 

Whilst being mindful of the potential impact of economic conditions the Company continues to expect 2015 to be another year of progress and remains confident about the long-term prospects for the business.

 

Zotefoams expects to announce its interim results for the six months ended 30 June 2015 on Tuesday 4 August 2015.

 

 

Enquiries:

Zotefoams plc

David Stirling, Group CEO

0208-664-1600

Clifford Hurst, Finance Director

FTI Consulting

0203-727-1000

Victoria Foster Mitchell/Simon Conway

 

 

Notes

 

1 Sales consolidates all external sales made by the joint-ventures as well as those made by Zotefoams plc and its subsidiaries.

2 Foreign exchange rates were:

 

H1:2015 average

H1:2014 average

30 Jun 2015

31 Dec 2014

Euro

1.378

1.223

1.412

1.289

USD

1.530

1.673

1.574

1.559

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK® is a registered trademark of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGGNZLMGKZZ
Date   Source Headline
12th Apr 20214:09 pmRNSDirector/PDMR Shareholding
25th Mar 20211:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:19 pmRNSCorrection: Preliminary Results
23rd Mar 20217:00 amRNSPreliminary Results
12th Mar 20212:53 pmRNSDirector/PDMR Shareholding
10th Mar 20211:12 pmRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
9th Mar 20213:05 pmRNSHolding(s) in Company
9th Mar 20211:55 pmRNSHolding(s) in Company
8th Mar 20213:04 pmRNSResult of secondary placing in Zotefoams plc
8th Mar 202112:00 pmRNSProposed secondary placing in Zotefoams plc
8th Mar 20217:00 amRNSNotice of results and investors presentation
5th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20217:00 amRNSProduction starts at new £23m plant in Poland
15th Feb 20217:00 amRNSPolish factory virtual tour and investor Q&A
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding - Replacement
12th Feb 20213:54 pmRNSDirector/PDMR Shareholding
12th Feb 20213:38 pmRNSDirector/PDMR Shareholding
8th Feb 20214:41 pmRNSSecond Price Monitoring Extn
8th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSOperational and Trading Update
12th Jan 20213:50 pmRNSDirector/PDMR Shareholding
14th Dec 20204:19 pmRNSDirector/PDMR Shareholding
12th Nov 20203:40 pmRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSOperational and Trading Update
22nd Oct 202010:36 amRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSExternal Auditor Appointment
1st Oct 20204:13 pmRNSDirector/PDMR Shareholding
16th Sep 20204:29 pmRNSDirector/PDMR Shareholding
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
9th Sep 20205:51 pmRNSHolding(s) in Company
1st Sep 20204:40 pmRNSSecond Price Monitoring Extn
1st Sep 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202010:54 amRNSDirector/PDMR Shareholding
12th Aug 20203:52 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSInterim Results
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Results
16th Jun 20205:05 pmRNSHolding(s) in Company
12th Jun 20203:25 pmRNSDirector/PDMR Shareholding
8th Jun 20202:06 pmRNSResult of the 2020 Annual General Meeting
2nd Jun 20208:00 amRNSOperational and Trading Update
22nd May 202012:07 pmRNSSecond Price Monitoring Extn
22nd May 202012:02 pmRNSPrice Monitoring Extension
14th May 20203:48 pmRNSIssue of Equity
14th May 20203:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.